ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 577, Pages eabc0170
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-01-21
DOI
10.1126/scitranslmed.abc0170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxic regulation of angiotensin‐converting enzyme 2 and Mas receptor in human CD34 + cells
- (2019) Shrinidh Joshi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors
- (2019) Ruchi Saxena et al. MELANOMA RESEARCH
- Current and Emerging Therapies for First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma
- (2018) Michael B. Atkins et al. CANCER TREATMENT REVIEWS
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Decarboxylation of Ang-(1–7) to Ala 1 -Ang-(1–7) leads to significant changes in pharmacodynamics
- (2018) Anja Tetzner et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation
- (2018) Matthias Becker et al. NEUROSCIENCE LETTERS
- The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
- (2018) Chloé Grasselly et al. Frontiers in Immunology
- Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
- (2017) Caroline Randrup Hansen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Local angiotensin II promotes adipogenic differentiation of human adipose tissue mesenchymal stem cells through type 2 angiotensin receptor
- (2017) Veronika Y. Sysoeva et al. Stem Cell Research
- Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients
- (2017) Peio Errarte et al. PLoS One
- Downregulation of ACE2/Ang-(1–7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry
- (2016) Changhui Yu et al. CANCER LETTERS
- G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase ANovelty and Significance
- (2016) Anja Tetzner et al. HYPERTENSION
- Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma
- (2016) Xiaoen Wang et al. Oncotarget
- The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma
- (2015) Guanxiong Ye et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway
- (2015) Shuai Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
- (2015) R. R. McKay et al. CLINICAL CANCER RESEARCH
- Angiotensin-(1–7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice
- (2015) Yixuan Shi et al. CLINICAL SCIENCE
- Beta Blockers Prevent Correlation of Plasma ACE2 Activity With Echocardiographic Parameters in Patients With Idiopathic Dilated Cardiomyopathy
- (2015) Yong Wang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Loss of angiotensin-converting enzyme 2 promotes growth of gallbladder cancer
- (2015) Huajie Zong et al. TUMOR BIOLOGY
- Renal cell carcinoma
- (2014) E. Jonasch et al. BMJ-British Medical Journal
- From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
- (2014) Sheila K. Patel et al. Frontiers in Physiology
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- Pharmacodynamic stimulation of thrombogenesis by angiotensin (1–7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy
- (2013) Huyen Pham et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- SENP1 deSUMOylates and Regulates Pin1 Protein Activity and Cellular Function
- (2013) Chun-Hau Chen et al. CANCER RESEARCH
- Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition
- (2013) YAN-RONG QIAN et al. ONCOLOGY REPORTS
- Accelerated hematopoietic recovery with angiotensin-(1–7) after total body radiation
- (2012) Kathleen E. Rodgers et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction
- (2010) Yong Wang et al. Circulation-Heart Failure
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Renal Cancer Resistance to Antiangiogenic Therapy Is Delayed by Restoration of Angiostatic Signaling
- (2010) R. S. Bhatt et al. MOLECULAR CANCER THERAPEUTICS
- Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP
- (2009) Yong Wang et al. JOURNAL OF CARDIAC FAILURE
- ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
- (2009) J. Chen et al. NUCLEIC ACIDS RESEARCH
- Does Arterial Spin-labeling MR Imaging–measured Tumor Perfusion Correlate with Renal Cell Cancer Response to Antiangiogenic Therapy in a Mouse Model?
- (2009) Rachel Schor-Bardach et al. RADIOLOGY
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
- (2008) Chantal Mercure et al. CIRCULATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started